KMT2A and acute myeloid leukemia: In particular, patients with inv(16) AML had significantly reduced expression when compared to the other subtypes (normal, p = 0.0002; complex, p < 0.0001; t(15;17), p = 0.0004; t(8;21), p = 0.0086; MLL, p = 0.0036).